share_log

HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $21

HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $21

HC Wainwright & Co.维持对ORIC制药的买入,将目标股价上调至21美元
Moomoo 24/7 ·  03/21 06:15

HC Wainwright & Co. analyst Robert Burns maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and raises the price target from $15 to $21.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持ORIC Pharmicals(纳斯达克股票代码:ORIC)的买入并将目标股价从15美元上调至21美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发